✦ LIBER ✦

Immunomodulatory therapy for inflammatory bowel disease

✍ Scribed by Kazuo Kusugami; Kenji Ina; Takafumi Ando; Kenji Hibi; Yuji Nishio; Hidemi Goto

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 408 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-004-1461-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mycophenolate mofetil therapy for refrac

Mycophenolate mofetil therapy for refractory inflammatory bowel disease

✍ S. Palaniappan; A. C. Ford; D. Greer; S. M. Everett; D. M. Chalmers; A. T. R. Ax 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Background: Mycophenolate mofetil (MMF) is an immunomodulatory drug, and its use in inflammatory bowel disease has previously been reported. The aim of this study was to review the Leeds Colitis Clinic experience of the safety and efficacy of MMF in treating patients with refractory Crohn's disease

Medical therapy for children with inflam

Medical therapy for children with inflammatory bowel disease

✍ Dr. Harland Winter; Richard Grand 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

About 30% of individuals with inflammatory bowel disease present before the age of 21 years (1). Despite this prevalence, most therapeutic agents are tested in adults with inflammatory bowel disease and pharmacokinetics, safety, and efficacy may never be studied in children and adolescents. In this

Optimizing thiopurine therapy in inflamm

Optimizing thiopurine therapy in inflammatory bowel disease

✍ Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet; Miles P. Sparrow 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Despite recent advances, the therapeutic armamentarium for inflammatory bowel disease (IBD) is still limited. In addition, a step-up approach is recommended for most IBD patients. Thus, optimizing each medical therapy before switching to another drug class is the rule in clinical practice. Conventio

Historical antecedents of inflammatory b

Historical antecedents of inflammatory bowel disease therapy

✍ Dr. Joseph B. Kirsner 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 985 KB

The increasingly "scientific" approach to the treatment of inflammatory bowel disease (IBD), that is, therapeutic interventions based on research, for example, in the development of anti-inflammatory agents to suppress pro-inflammatory molecules, is in sharp contrast to the arbitrary and sometimes b

Standards for trials of therapy in infla

Standards for trials of therapy in inflammatory bowel disease

✍ Dr. L. R. Sutherland; S. Hanauer; J. Scholmerich 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 724 KB

Inflammatory Bowel Disease

✍ Aravind Suppiah; Jonathon Cowley; Chris Macklin 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 144 KB